TY - JOUR
T1 - Analysis of spinal muscular atrophy patients from the spinal muscular atrophy and muscular dystrophy registry of Pakistan
AU - Aziz, Bisma
AU - Arif, Ahmed A.
AU - Kazi, Kulsum
AU - Kirmani, Salman
AU - Ansar, Zeeshan
AU - Nasir, Asghar
AU - Ibrahim, Shahnaz Hamid
AU - Ahmed, Khairunnisa Mukhtiar
AU - Hasan, Zahra
AU - Khan, Sara
N1 - Publisher Copyright:
© The Author(s) 2024. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
PY - 2025/3
Y1 - 2025/3
N2 - Background: Spinal Muscular Atrophy (SMA) leads to motor neuron loss, with progressive muscle weakness and wasting. Nationwide registries for neuromuscular diseases are pivotal for assessing epidemiology, preparing for clinical trials, and for adopting standardized management guidelines. Objectives: This paper aims to present data gathered during the establishment of Pakistan's inaugural registry for genetically confirmed SMA cases. Methods: In this retrospective study, 215 participants with genetically confirmed SMA were recruited. Telephonic interviews were conducted to collect data for the Muscular Disease Registry of Pakistan that was analyzed using STATA version 17.0. Results: SMA type 1 was the most common type (71.2%, n = 153). Amongst patients who were tested for survival motor neuron (SMN2) copies, the majority (84.4%, n = 168) had two SMN2 copies. SMA types were significantly associated with the ability to sit (p < 0.001) and walk (p < 0.001), and usage of a wheelchair (p = 0.0054). SMN2 copy numbers were significantly associated with the ability to sit (p = 0.020) and walk (p = 0.031). Conclusions: This study highlights the high prevalence of SMA genotypes and phenotypes associated with severe disease in our population. Our findings reiterate the challenging prognosis for Pakistani children with SMA and underscore the necessity of the development of nationwide newborn screening programs and making treatments available.
AB - Background: Spinal Muscular Atrophy (SMA) leads to motor neuron loss, with progressive muscle weakness and wasting. Nationwide registries for neuromuscular diseases are pivotal for assessing epidemiology, preparing for clinical trials, and for adopting standardized management guidelines. Objectives: This paper aims to present data gathered during the establishment of Pakistan's inaugural registry for genetically confirmed SMA cases. Methods: In this retrospective study, 215 participants with genetically confirmed SMA were recruited. Telephonic interviews were conducted to collect data for the Muscular Disease Registry of Pakistan that was analyzed using STATA version 17.0. Results: SMA type 1 was the most common type (71.2%, n = 153). Amongst patients who were tested for survival motor neuron (SMN2) copies, the majority (84.4%, n = 168) had two SMN2 copies. SMA types were significantly associated with the ability to sit (p < 0.001) and walk (p < 0.001), and usage of a wheelchair (p = 0.0054). SMN2 copy numbers were significantly associated with the ability to sit (p = 0.020) and walk (p = 0.031). Conclusions: This study highlights the high prevalence of SMA genotypes and phenotypes associated with severe disease in our population. Our findings reiterate the challenging prognosis for Pakistani children with SMA and underscore the necessity of the development of nationwide newborn screening programs and making treatments available.
KW - Pakistan
KW - SMA
KW - neuromuscular disorders
KW - registry
KW - spinal muscular atrophy
UR - https://www.scopus.com/pages/publications/105004235348
U2 - 10.1177/22143602241301657
DO - 10.1177/22143602241301657
M3 - Article
C2 - 39973405
AN - SCOPUS:105004235348
SN - 2214-3599
VL - 12
SP - 260
EP - 270
JO - Journal of Neuromuscular Diseases
JF - Journal of Neuromuscular Diseases
IS - 2
ER -